Abstract
Brentuximab Vedotin Monotherapy and in Combination with Dacarbazine in Frontline Treatment of Hodgkin Lymphoma in Patients Aged 60 Years and Above: Interim Results of a Phase 2 Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have